Ocular Diseases Drug Discovery

Register 3 for the price of 2 with the coupon code rcdvb!

registration button

registration button

Subscribe for updates

Dear Colleague,

The 10th Ocular Diseases Drug Discovery Conference is scheduled for March 20-21, 2018 in San Diego, CA. We are excited to have representatives from the industry and academic sectors to discuss technologies and targets that are continually changing the way ocular diseases are treated. Drug delivery is always improving as we look at for better methods to penetrate anterior and posterior segments of the eye. Successes in gene therapy and regenerative medicine are proving to be interesting approaches to discuss in detail preclinically and clinically. We are inviting leading scientists, researchers, and experts to discuss and collaborate on combating various ocular diseases.

headshots1 Jerry Cagle head 5813 1 - Ocular Diseases Drug DiscoveryJerry Cagle
Independent Pharmaceuticals Professional
Former VP, R&D, Alcon
carl romano 1 - Ocular Diseases Drug DiscoveryCarl Romano
Executive Director, Ophthalmology

Linda Zangwill - Ocular Diseases Drug Discovery


Linda Zangwill 
Professor, Ophthalmology
UC San Diego
kenney cristina - Ocular Diseases Drug DiscoveryCristina Kenney 
Professor & Director, Ophthalmology Research
UC Irvine
  1. Opening Keynote Session: Historical Perspective and State of the Industry
  2. Preclinical Development of Novel Technologies
  3. Translational Studies and Lessons Learned
  4. Panel: Ophthalmology Funding Environment
  5. Panel: Regulatory Challenges
  6. Partnering between Industry, Academia, and CROs to Advance Research
  7. Start-Up Showcase (Lunch Session)
  8. Closing Keynote Session: Predictions for Future

We hope to see you there!

Best regards,
The 2018 Advisory Committee

Matthias Birkhoff, Aptar
Oscar Cuzzani, BioTime
Emmett Cunningham, Clarus Ventures
Rafal Farjo, EyeCRO LLC
Rangaramujam Kannan, John Hopkins University